These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 29144508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Critical role for the NLRP3 inflammasome during acute lung injury.
    Grailer JJ, Canning BA, Kalbitz M, Haggadone MD, Dhond RM, Andjelkovic AV, Zetoune FS, Ward PA.
    J Immunol; 2014 Jun 15; 192(12):5974-83. PubMed ID: 24795455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury.
    Yang Y, Yang F, Yu X, Wang B, Yang Y, Zhou X, Cheng R, Xia S, Zhou X.
    Biomed Pharmacother; 2019 Apr 15; 112():108664. PubMed ID: 30784935
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanism of chlorogenic acid reducing lipopolysaccharide-induced acute lung injury in mice by regulating miR-223/NLRP3 axis.
    Liu C, Cheng X, Sun J, Zhang S, Zhang Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar 28; 47(3):280-288. PubMed ID: 35545320
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L, Zhang L, Kang K, Fei D, Gong R, Cao Y, Pan S, Zhao M, Zhao M.
    Biomed Pharmacother; 2016 Dec 28; 84():130-138. PubMed ID: 27643555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L, Fei D, Gong R, Yang W, Yu W, Pan S, Zhao M, Zhao M.
    Inflamm Res; 2016 Nov 28; 65(11):905-915. PubMed ID: 27412237
    [Abstract] [Full Text] [Related]

  • 16. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A, Kashir J.
    Med Hypotheses; 2020 Oct 28; 143():109906. PubMed ID: 32505910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway.
    Chen H, Ding Y, Chen W, Feng Y, Shi G.
    Drug Des Devel Ther; 2019 Oct 28; 13():1545-1554. PubMed ID: 31123394
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA‑33 regulates the NLRP3 inflammasome signaling pathway in macrophages.
    Xie Q, Wei M, Zhang B, Kang X, Liu D, Zheng W, Pan X, Quan Y, Liao D, Shen J.
    Mol Med Rep; 2018 Feb 28; 17(2):3318-3327. PubMed ID: 29257274
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.